Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy

Head and Neck

Volumn 36, Issue 11, 2014, Pages 1589-1595

  Demiroz, Candan ^a,b   Vainshtein, Jeffrey M ^b   Koukourakis, Georgios V ^b,c   Gutfeld, Orit ^b,d   Prince, Mark E ^b   Bradford, Carol R ^b   Wolf, Gregory T ^b   McLean, Scott ^b   Worden, Francis P ^b   Chepeha, Douglas B ^b   Schipper, Matthew J ^e   McHugh, Jonathan B ^b   Eisbruch, Avraham ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Saint Savvas Anticancer Institute of Athens   (Greece)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

human papillomavirus; neck dissection; radiation therapy; unknown primary

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DISTANT METASTASIS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADJUVANT THERAPY; CANCER STAGING; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION STUDY; FACTUAL DATABASE; HEAD AND NECK NEOPLASMS; IMAGE GUIDED RADIOTHERAPY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEOPLASMS, UNKNOWN PRIMARY; NONPARAMETRIC TEST; PATHOLOGY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SECONDARY; SURVIVAL; TUMOR INVASION; UNITED STATES;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84929514059     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23479     Document Type: Article

References (39)

1. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ, DeSanto LW,. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992; 23: 743-749.
2. Weir L, Keane T, Cummings B, et al., Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995; 35: 206-211.
3. Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Ang KK,. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998; 20: 674-681.
4. de Braud F, al-Sarraf M,. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 1993; 20: 273-278.
5. Reddy SP, Marks JE,. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997; 37: 797-802.
6. Iganej S, Kagan R, Anderson P, et al., Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002; 24: 236-246.
7. Mendenhall WM, Million RR, Cassisi NJ,. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986; 12: 733-740.
8. Machtay M, Moughan J, Trotti A, et al., Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
9. Dagan R, Morris CG, Kirwan JM, et al., Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation. Laryngoscope 2010; 120: 945-952.
10. Aslani M, Sultanem K, Voung T, Hier M, Niazi T, Shenouda G,. Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: is there a need for neck dissection? Head Neck 2007; 29: 585-590.
11. Ang KK, Harris J, Wheeler R, et al., Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
12. Freeman D, Mendenhall WM, Parsons JT, Million RR,. Unknown primary squamous cell carcinoma of the head and neck: is mucosal irradiation necessary? Int J Radiat Oncol Biol Phys 1992; 23: 889-890.
13. Davidson BJ, Spiro RH, Patel S, Patel K, Shah JP,. Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg 1994; 168: 395-399.
14. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP,. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy with palliative intent. Radiother Oncol 2001; 59: 319-321.
15. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB,. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129.
16. Strojan P, Anicin A,. Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour. Radiother Oncol 1998; 49: 33-40.
17. Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA,. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30: 28-34.
18. Patel RS, Clark J, Wyten R, Gao K, O'Brien CJ,. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach. Arch Otolaryngol Head Neck Surg 2007; 133: 1282-1287.
19. Mack Y, Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR,. Squamous cell carcinoma of the head and neck: management after excisional biopsy of a solitary metastatic neck node. Int J Radiat Oncol Biol Phys 1993; 25: 619-622.
20. Christiansen H, Hermann RM, Martin A, Nitsche M, Schmidberger H, Pradier O,. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature. Strahlenther Onkol 2005; 181: 355-362.
21. Wallace A, Richards GM, Harari PM, et al., Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol 2011; 32: 286-290.
22. Nguyen C, Shenouda G, Black MJ, Vuong T, Donath D, Yassa M,. Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites. Head Neck 1994; 16: 58-63.
23. Nieder C, Gregoire V, Ang KK,. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001; 50: 727-733.
24. Frank SJ, Rosenthal DI, Petsuksiri J, et al., Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010; 78: 1005-1010.
25. El-Mofty SK, Zhang MQ, Davila RM,. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol 2008; 2: 163-168.
26. Park GC, Lee M, Roh JL, et al., Human papillomavirus and p16 detection in cervical lymph node metastases from an unknown primary tumor. Oral Oncol 2012; 48: 1250-1256.
27. Zengel P, Assmann G, Mollenhauer M, et al., Cancer of unknown primary originating from oropharyngeal carcinomas are strongly correlated to HPV positivity. Virchows Arch 2012; 461: 283-290.
28. Maxwell JH, Kumar B, Feng FY, et al., HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck 2010; 32: 562-567.
29. Punwaney R, Brandwein MS, Zhang DY, et al., Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck 1999; 21: 21-29.
30. Armas GL, Su CY, Huang CC, Fang FM, Chen CM, Chien CY,. The impact of virus in N3 node dissection for head and neck cancer. Eur Arch Otorhinolaryngol 2008; 265: 1379-1384.
31. Lee WY, Hsiao JR, Jin YT, Tsai ST,. Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck 2000; 22: 336-340.
32. Macdonald MR, Freeman JL, Hui MF, et al., Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma. Head Neck 1995; 17: 487-493.
33. Walter MA, Menarguez-Palanca J, Peiper SC,. Epstein-Barr virus detection in neck metastases by polymerase chain reaction. Laryngoscope 1992; 102: 481-485.
34. Tribius S, Hoffmann AS, Bastrop S, et al., HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. Oral Oncol 2012; 48: 1178-1184.
35. Perkins SM, Spencer CR, Chernock RD, et al., Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg 2012; 138: 656-661.
36. Chaturvedi AK, Engels EA, Pfeiffer RM, et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
37. Denis F, Garaud P, Bardet E, et al., Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76.
38. Forastiere AA, Goepfert H, Maor M, et al., Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
39. Bernier J, Cooper JS, Pajak TF, et al., Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005; 27: 843-850.